Proteasome inhibitors prevent the degradation of familial Alzheimer's disease-linked presenilin 1 and potentiate Aβ42 recovery from human cells

Molecular Medicine

Volumn 4, Issue 3, 1998, Pages 147-157

  Marambaud, Philippe ^a   Ancolio, Karine ^a   Lopez Perez, Elvira ^a   Checler, Frédéric ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PRESENILIN 1;

ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 14; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENILE PLAQUE;

EID: 0031950118     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401912     Document Type: Article

References (40)

1. Lemere CA, Lopera F, Kosik KS, et al. (1996) The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nat. Med. 2: 1146-1150.
2. Mann DMA, Iwatsubo T, Cairns NJ, et al. (1997) Amyloid β protein (Aβ) deposition in chromosome 14-linked Alzheimer's disease: Predominance of Aβ42(43). Ann. Neurol. 40: 149-156.
3. Mann DMA, Iwatsubo T, Nochlin D, Sumi SM, Levy-Lahad E, Bird TD. (1997) Amyloid (Aβ) deposition in Chromosome 1-linked Alzheimer's disease: The Volga German family. Ann. Neurol. 41: 52-57.
4. Borchelt DR, Thinakaran G, Eckman CB, et al. (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 in vitro and in vivo. Neuron 17: 1005-1013.
5. Gearing M, Tigges J, Mori H, Mirra SS. (1996) Aβ40 is a major form of β-amyloid in human primates. Neurobiol. Aging 17: 903-908.
6. Xia W, Zhang J, Kholodenko D, et al. (1997) Enhanced production and oligomerization of the 42-residue amyloid β-protein by chinese hamster ovary cells stably expressing mutant presenilins. J. Biol. Chem. 272: 7977-7982.
7. Tomita T, Maruyama K, Saido TC, et al. (1997) The presenilin 2 mutation (N14II) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue. Proc. Natl. Acad. Sci. USA 94: 2025-2030.
8. Duff K, Eckman C, Zehr C, et al. (1996) Increased amyloid-β42(43) in brains expressing mutant presenilin 1. Nature 383: 710-713.
9. Ancolio K, Marambaud P, Dauch P, Checler F. (1997) α-secretase-derived product of β amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease. J. Neurochem. 69: 2495-2499.
10. Kovacs DM, Fausett HJ, Page KJ, et al. (1996) Alzheimer-associated presenilins 1 and 2: Neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat. Med. 2: 224-229.
11. Cook DG, Sung JC, Golde TE, et al. (1996) Expression and analysis of presenilin 1 in a human neuronal system: Localization in cell bodies and dendrites. Proc. Natl. Acad. Sci. USA 93: 9223-9228.
12. Walter J, Capell A, Grünberg J, et al. (1996) The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Mol. Med. 2: 673-691.
13. Dewji NN, Singer SJ. (1996) Specific transcellular binding between membrane proteins crucial to Alzheimer disease. Proc. Natl. Acad. Sci. USA 93: 12575-12580.
14. Weidemann A, Paliga K, Dürrwang U, et al. (1997) Formation of stable complexes between two Alzheimer's disease gene products: Presenilin-2 and β-amyloid precursor protein. Nat. Med. 3: 328-332.
15. Marambaud P, Chevallier N, Barelli H, Wilk S, Checler F. (1997) Proteasome contributes to the α-secretase pathway of amyloid precursor protein in human cells. J. Neurochem. 68: 698-703.
16. Marambaud P, Lopez-Perez E, Wilk S, Checler F. (1997) Constitutive and protein kinase C-regulated secretary cleavage of Alzheimer's β amyloid precursor protein: Different control of early and late events by the proteasome. J. Neurochem. 69: 2500-2505.
17. Marambaud P, Wilk S, Checler F. (1996) Protein kinase A phosphorylation of the proteasome: A contribution to the α-secretase pathway in human cells. J. Neurochem. 67: 2616-2619.
18. Dauch P, Champigny G, Ricci J-E, Checler F. (1997) Lack of effect of presenilin1, βAPP and their Alzheimer's disease-related mutated forms on xenopus oocytes membrane current. Neurosci. Lett. 221: 1-4.
19. Thinakaran G, Borchelt DR, Lee MK, et al. (1996) Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17: 181-190.
20. Chevallier N, Jiracek J, Vincent B, et al. (1997) Examination of the role of endopeptidase 3.4.24.15 in Aβ secretion by human transfected cells. Br. J. Pharmacol. 121: 556-562.
21. Barelli H, Lebeau A, Vizzavona J, et al. (1997) Characterization of new polyclonal antibodies specific for 40 and 42 aminoacid-long amyloid β peptides: Their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases. Mol. Med. 3: 695-707.
22. Fenteany G, Standaert R, Lane WS, Choi S, Corey EJ, Schreiber SL. (1995) Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268: 726-731.
23. Pereira ME, Yu B, Wilk S. (1992) Enzymatic changes of the bovine pituitary multicatalytic proteinase complex induced by magnesium ions. Arch. Biochem. Biophys. 294: 1-8.
24. Ward RV, Davis JB, Gray CW, et al. (1996) Presenilin-1 is processed into two major cleavage products in neuronal cell lines. Neurodegeneration 5: 293-298.
25. De Strooper B, Beullens M, Contreras B, et al. (1997) Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. J. Biol. Chem. 272: 3590-3598.
26. Seeger M, Nordstedt C, Petanceska S, et al. (1997) Evidence for phosphorylation and oligomeric assembly of presenilin 1. Proc. Natl. Acad. Sci. USA 94: 5090-5094.
27. Walter J, Grünberg J, Capell A, et al. (1997) Proteolytic processing of the Alzheimer disease associated presenilin-1 generates an in vivo substrate for protein kinase C. Proc. Natl. Acad. Sci. USA 94: 5349-5354.
28. Varhavski, A. (1997) The ubiquitin system. Trends Neurosci. 22: 383-387.
29. Kim TW, Pettingell WH, Hallmark OG, Moir RD, Wasco W, Tanzi RE. (1997) Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells. J. Biol. Chem. 272: 11006-11010.
30. Mengual E, Aritzi P, Rodrigo J, Gimenez-Amaya JM, Castano JG. (1996) Immunohistochemical distribution and electron microscopic subcellular localization of the proteasome in the rat CNS. J. Neurosci. 16: 6331-6341.
31. Palmer A, Rivett AJ, Thomson S, et al. (1996) Subpopulations of proteasomes in rat liver nuclei, microsomes and cytosol. Biochem. J. 316: 401-407.
32. Oda K, Ikehara Y, Omura S. (1996) Lactacystin, an inhibitor of the proteasome, blocks the degradation of a mutant precursor of glycosylphosphatidyl inositol-linked protein in a pre-Golgi compartment. Biochem. Biophys. Res. Commun. 219: 800-805.
33. Werner ED, Brodsky JL, McCracken AA. (1996) Proteasome-dependent endoplasmic reticulum-associated protein degradation: An unconventional route to a familiar fate. Proc. Natl. Acad. Sci. USA 93: 13797-13801.
34. Fuller SJ, Storey E, Li QX, Smith I, Beyreuther K, Master CL. (1995) Intracellular production of βA4 amyloid of Alzheimer's disease: Modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor protein. Biochemistry 34: 8091-8098.
35. Haass C. (1996) Presenile because of presenilin: The presenilin genes and early onset Alzheimer's disease. Curr. Opin. Neurol. 9: 254-259.
36. Hardy J, Allsop D. (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12: 383-388.
37. Checler F. (1998) Presenilins. Mol. Neurobiol. (in press).
38. Checler F. (1995) Processing of the β-amyloid precursor protein and its regulation in Alzhei-mer's disease. J. Neurochem. 65: 1431-1444.
39. Rivett AJ. (1989) The multicatalytic proteinase. Multiple proteolytic activities. J. Biol. Chem. 264: 12215-12219.
40. Rechsteiner M, Hoffman L, Dubiel W. (1993) The multicatalytic and 26S proteases. J. Biol. Chem. 268: 6065-6068.